Enoxaparin-Induced Liver Injury

Enoxaparin, a form of low-molecular-weight heparin, can cause a rare, underreported, and often reversible form of hepatocellular injury. This report describes a case of enoxaparin-induced hepatotoxicity in a 61-year-old male diagnosed with pulmonary embolism. Elevations of liver enzymes were noted w...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehershahi, Shehriyar, Mantri, Nikhitha, Kumar, Aneesh, Danial, Shaikh, Harish, Patel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315174/
https://www.ncbi.nlm.nih.gov/pubmed/32595436
http://dx.doi.org/10.1159/000508471
_version_ 1783550206559649792
author Mehershahi, Shehriyar
Mantri, Nikhitha
Kumar, Aneesh
Danial, Shaikh
Harish, Patel
author_facet Mehershahi, Shehriyar
Mantri, Nikhitha
Kumar, Aneesh
Danial, Shaikh
Harish, Patel
author_sort Mehershahi, Shehriyar
collection PubMed
description Enoxaparin, a form of low-molecular-weight heparin, can cause a rare, underreported, and often reversible form of hepatocellular injury. This report describes a case of enoxaparin-induced hepatotoxicity in a 61-year-old male diagnosed with pulmonary embolism. Elevations of liver enzymes were noted within 1 week of starting the drug, followed by a dramatic improvement upon its discontinuation, with subsequent normalization in the following days.
format Online
Article
Text
id pubmed-7315174
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-73151742020-06-26 Enoxaparin-Induced Liver Injury Mehershahi, Shehriyar Mantri, Nikhitha Kumar, Aneesh Danial, Shaikh Harish, Patel Case Rep Gastroenterol Single Case Enoxaparin, a form of low-molecular-weight heparin, can cause a rare, underreported, and often reversible form of hepatocellular injury. This report describes a case of enoxaparin-induced hepatotoxicity in a 61-year-old male diagnosed with pulmonary embolism. Elevations of liver enzymes were noted within 1 week of starting the drug, followed by a dramatic improvement upon its discontinuation, with subsequent normalization in the following days. S. Karger AG 2020-06-10 /pmc/articles/PMC7315174/ /pubmed/32595436 http://dx.doi.org/10.1159/000508471 Text en Copyright © 2020 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Mehershahi, Shehriyar
Mantri, Nikhitha
Kumar, Aneesh
Danial, Shaikh
Harish, Patel
Enoxaparin-Induced Liver Injury
title Enoxaparin-Induced Liver Injury
title_full Enoxaparin-Induced Liver Injury
title_fullStr Enoxaparin-Induced Liver Injury
title_full_unstemmed Enoxaparin-Induced Liver Injury
title_short Enoxaparin-Induced Liver Injury
title_sort enoxaparin-induced liver injury
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315174/
https://www.ncbi.nlm.nih.gov/pubmed/32595436
http://dx.doi.org/10.1159/000508471
work_keys_str_mv AT mehershahishehriyar enoxaparininducedliverinjury
AT mantrinikhitha enoxaparininducedliverinjury
AT kumaraneesh enoxaparininducedliverinjury
AT danialshaikh enoxaparininducedliverinjury
AT harishpatel enoxaparininducedliverinjury

Ejemplares similares